Admission Date:  [**2165-3-2**]              Discharge Date:   [**2165-3-8**]  Date of Birth:  [**2135-8-29**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 148**] Chief Complaint: Epigastric pain and nausea.
Major Surgical or Invasive Procedure: None   History of Present Illness: 29 year old male admitted last night with sudden onset of epigastric pain and nausea.
No fever or chills.
States he had a similar episode and was hospitalized for pancreatitis [**2164-11-16**] where he was admitted with 1 day h/o abdominal pain, initial elevation of lipase and amylase consistent with gallstone pancreatitis.
The CT scan obtained during that admission revealed a peripancreatic fluid without evidence of pancreatic ductal dilatation or pancreatic necrosis.
No gallstones were identified on CT scan.
During the same admission within three days, his hyperamylasemia and hyperlipasemia returned to [**Location 213**].
No peripancreatic or pericholecystic fluid.
Past Medical History: PMHx: GERD - Patient had EDG done at [**Hospital6 5016**] in early [**2164**] after which his PCP started [**Name Initial (PRE) **] PPI, no Ulcer disease per pateint.
Physical Exam: On Admission: Gen: resting comfortably HEENT: no jaundice, PERRL, trachea midline Abd: soft, mildly distended, no rebound or guarding, tenderness over epigastrium, positive bowel sounds CVS: tachycardic, positive S1 and S2, no S3 or S4 Chest: clear to auscultation bilaterally Ext: no edema, positive distal pulses   Pertinent Results: On Admission:  [**2165-3-2**] 05:18PM   AMYLASE-530* [**2165-3-2**] 05:18PM   LIPASE-1654* [**2165-3-2**] 08:20AM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-0.2 PH-5.0 LEUK-NEG [**2165-3-2**] 08:18AM   LACTATE-3.5* [**2165-3-2**] 04:15AM   GLUCOSE-173* UREA N-16 CREAT-0.8 SODIUM-139 POTASSIUM-3.7 CHLORIDE-97 TOTAL CO2-26 ANION GAP-20 [**2165-3-2**] 04:15AM   ALT(SGPT)-48* AST(SGOT)-43* ALK PHOS-119 TOT BILI-0.2 DIR BILI-0.1 INDIR BIL-0.1 [**2165-3-2**] 04:15AM   LIPASE-4605* [**2165-3-2**] 04:15AM   ALBUMIN-4.9 [**2165-3-2**] 04:15AM   WBC-20.5*# RBC-4.93# HGB-15.9# HCT-45.3# MCV-92# MCH-32.3* MCHC-35.1* RDW-12.9 [**2165-3-2**] 04:15AM   NEUTS-83.5* LYMPHS-13.5* MONOS-2.3 EOS-0.2 BASOS-0.4 [**2165-3-2**] 04:15AM   PLT COUNT-413# .
No fluid seen in right upper quadrant.
No findings of acute cholecystitis.
A left retrocardiac consolidation is noted, non-specific, possibly atelectasis or a focus of aspiration or infection.
There is no pleural effusion or pneumothorax.
There is no evidence of pneumoperitoneum.
Inflammatory change and fluid surrounding the pancreas, consistent with acute pancreatitis.
No evidence of necrotizing pancreatitis, pancreatic pseudocyst, or vascular involvement.
No biliary obstruction or biliary stones.
[**2165-3-7**] MRCP: **PRELIMINARY REPORT**: Findings consistent with acute pancreatitis, no evidence of complications, such as no necrosis or peripancreatic fluid collection.
No cholelithiasis or choledocholithiasis.
Brief Hospital Course: The patient was admitted to the General Surgical Service in the TSICU on [**2165-3-2**] for evaluation and treatment of epigastric pain and elevated pancreatic enzymes, initially consistent with gallstone pancreatitis.
Admission abdominal ultra-sound showed no fluid seen in right upper quadrant and no findings of acute cholecystitis.
Abdominal CT revealed inflammatory change and fluid surrounding the pancreas, consistent with acute pancreatitis.
There was no evidence of necrotizing pancreatitis, pancreatic pseudocyst, vascular involvement, or biliary obstruction or biliary stones.
Findings now consistent with recurrent pancreatitis.
He was made NPO, given IV fluid rescusitation, a foley catheter was placed, and Dilaudid IV PRN for pain with good effect.
Neuro: The patient was changed to a Dilaudid PCA with good effect and adequate pain control.
When tolerating oral intake, the patient was transitioned to oral pain medications with continued good pain control.
Good pulmonary toilet, early ambulation and incentive spirrometry were encouraged throughout hospitalization.
Hyperamylasemia and hyperlipasemia significantly improved over the next three days.
On [**3-7**], diet was returned to clears as he experienced a moderate increase in lipase to 502, and mild increase of amylase to 117.
An MRCP was performed, which demonstrated findings consistent with acute pancreatitis, no evidence of complications, such as no necrosis or peripancreatic fluid collection.
No cholelithiasis or choledocholithiasis.
Pancreatic enzymes were again mildly elevated on [**3-8**] with an Amylase of 171 (up from 115) and a lipase of 664 (up from 475).
ID: The patient's white blood count and fever curves were closely watched for signs of infection.
Admission blood cultures revealed no growth.
At the time of discharge, the patient was doing well, afebrile with stable vital signs.
The patient was tolerating a clear diet, ambulating, voiding without assistance, and pain was well controlled.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation.
Disp:*30 Tablet(s)* Refills:*0*  Discharge Disposition: Home  Discharge Diagnosis: Recurrent pancreatitis   Discharge Condition: Mental Status:Clear and coherent Level of Consciousness:Alert and interactive Activity Status:Ambulatory - Independent   Discharge Instructions: Please resume all regular home medications , unless specifically advised not to take a particular medication.
